MalaysiaHealthcare and life sciences2018 – ongoingMinistry of Health
DR.MATA diabetic-retinopathy screening
Malaysia piloted retinal-image AI that the health ministry said produced reports within 30 seconds
Problem
Primary-care clinics lacked trained retinal-image graders. Delayed reports disrupted follow-up for patients with diabetes.
Approach
A ministry team began DR.MATA in 2018 and developed it with Qmed Asia. The system assessed retinal images for diabetic retinopathy and supported referral decisions. Uncertain cases received review and informed subsequent model training.
Results
Takeaway
The ministry reported higher screening uptake at pilot sites without quantifying the increase. Its validation figure described agreement with expert graders.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Production and quality
- Innovation type
- Process innovation
- AI technology
- Computer vision
- Adoption
- Partner co-development
- Evidence
- Company's own claim
Sources
Source summaries
The Edge interviewed a ministry official about development and pilot deployment. It reported the ministry's turnaround and validation claims.
Full details are in the original sources.
